# üìä B·∫£ng Tham Kh·∫£o Œ±/Œ≤

## üéØ Gi·ªõi thi·ªáu

B·∫£ng n√†y t·ªïng h·ª£p c√°c gi√° tr·ªã Œ±/Œ≤ ƒë∆∞·ª£c ƒë·ªÅ xu·∫•t cho c√°c lo·∫°i m√¥ v√† u kh√°c nhau, d·ª±a tr√™n:
- **QUANTEC** (Quantitative Analysis of Normal Tissue Effects in the Clinic)
- **PENTEC** (Pediatric Normal Tissue Effects in the Clinic)
- C√°c nghi√™n c·ª©u l√¢m s√†ng ƒë∆∞·ª£c c√¥ng b·ªë

---

## üìã B·∫£ng Tham Kh·∫£o ƒê·∫ßy ƒê·ªß

### üéØ TUMOR (U)

| Lo·∫°i U | Œ±/Œ≤ (Gy) | Ph·∫°m vi | Ghi ch√∫ | T√†i li·ªáu |
|--------|----------|---------|---------|----------|
| **U tuy·∫øn ti·ªÅn li·ªát** (Prostate) | **1.5** | 0.8-3.0 | Low Œ±/Œ≤ ‚Üí ∆∞u ti√™n hypofractionation | SpringerLink |
| **U v√∫** (Breast) | **3.5** | 2.0-5.0 | Nhi·ªÅu ph√¢n t√≠ch cho ~3-4 Gy | Spandidos |
| **U ƒë·∫ßu c·ªï** (Head & Neck) | **10** | 8-12 | Carcinoma r·∫Øn th∆∞·ªùng d√πng 10 Gy | SpringerLink |
| **U ph·ªïi NSCLC** | **12** | 10-15 | D·ªØ li·ªáu SBRT g·ª£i √Ω 10-16 Gy | PubMed |

### üß† H·ªÜ TH·∫¶N KINH (Late Effects)

| C∆° quan | Œ±/Œ≤ (Gy) | Ph·∫°m vi | Ghi ch√∫ | T√†i li·ªáu |
|---------|----------|---------|---------|----------|
| **T·ªßy s·ªëng** (Spinal Cord) | **2.0** | 0.9-5.0 | D√πng gi√° tr·ªã b·∫£o th·ªß 2 Gy cho EQD2 | redjournal.org |
| **N√£o** (Brain Necrosis) | **2.5** | 2.0-3.0 | Late reacting CNS tissues ‚Üí low Œ±/Œ≤ | QUANTEC/PENTEC |
| **D√¢y TK th·ªã gi√°c** (Optic Nerve/Chiasm) | **2.5** | 2.0-3.0 | T∆∞∆°ng t·ª± brainstem, d√πng b·∫£o th·ªß 2-3 | PMC |
| **Th·ªßy tinh th·ªÉ** (Lens) | **1.0** | 0.7-1.0 | Cataract l√† m√¥ mu·ªôn, Œ±/Œ≤ r·∫•t th·∫•p | PubMed |

### ‚ù§Ô∏è TIM PH·ªîI TH·∫¨N GAN

| C∆° quan | Œ±/Œ≤ (Gy) | Ph·∫°m vi | Ghi ch√∫ | T√†i li·ªáu |
|---------|----------|---------|---------|----------|
| **Tim** (Heart) | **3.0** | 1.0-3.0 | Late cardiac injury, d√πng 3 b·∫£o th·ªß | redjournal.org |
| **Ph·ªïi** (Lung) | **3.0** | 2.0-4.0 | Pneumonitis/fibrosis, th∆∞·ªùng d√πng 3 | redjournal.org |
| **Th·∫≠n** (Kidney) | **2.5** | 2.0-3.0 | Late renal endpoints | jnm.snmjournals |
| **Gan** (Liver) | **2.5** | 2.0-3.0 | RILD (Radiation-Induced Liver Disease) | QUANTEC/PMC |

### üîª TI·ªÇU KHUNG

| C∆° quan | Œ±/Œ≤ (Gy) | Ph·∫°m vi | Ghi ch√∫ | T√†i li·ªáu |
|---------|----------|---------|---------|----------|
| **Tr·ª±c tr√†ng** (Rectum) | **3.0** | 2.5-3.5 | Late proctitis/fibrosis | redjournal.org |
| **B√†ng quang** (Bladder) | **3.0** | 2.5-3.5 | Late cystitis/stricture | PMC |

### ü©π DA X∆Ø∆†NG T·ª¶Y

| M√¥ | Œ±/Œ≤ (Gy) | Ph·∫°m vi | Ghi ch√∫ | T√†i li·ªáu |
|----|----------|---------|---------|----------|
| **Da (Acute)** | **10** | 8-10 | Erythema - early responding | ScienceDirect |
| **Da (Late)** | **3.0** | 2.5-3.5 | Fibrosis/telangiectasia | PMC |
| **X∆∞∆°ng** (Bone) | **3.0** | 2.5-3.5 | Late fracture/necrosis | PMC |
| **T·ªßy x∆∞∆°ng** (Bone Marrow) | **10** | 8-12 | Acute hematopoietic effects | ScienceDirect |

---

## üéì Nguy√™n t·∫Øc s·ª≠ d·ª•ng

### 1. Ph√¢n bi·ªát Early vs Late Effects

**Early responding tissues** (Œ±/Œ≤ cao ~10 Gy):
- ‚úÖ U (tumor)
- ‚úÖ Da c·∫•p (acute skin)
- ‚úÖ Ni√™m m·∫°c (mucosa)
- ‚úÖ T·ªßy x∆∞∆°ng (bone marrow)

**Late responding tissues** (Œ±/Œ≤ th·∫•p ~2-3 Gy):
- ‚úÖ T·ªßy s·ªëng (spinal cord)
- ‚úÖ N√£o (brain)
- ‚úÖ Tim ph·ªïi th·∫≠n gan
- ‚úÖ Da mu·ªôn (late skin)

### 2. √ù nghƒ©a l√¢m s√†ng

**Œ±/Œ≤ th·∫•p (1-3 Gy)**:
- R·∫•t nh·∫°y c·∫£m v·ªõi li·ªÅu/fx cao
- Hypofractionation c√≥ th·ªÉ tƒÉng ƒë·ªôc t√≠nh
- C·∫ßn th·∫≠n tr·ªçng khi tƒÉng li·ªÅu/fx

**Œ±/Œ≤ cao (8-12 Gy)**:
- √çt nh·∫°y c·∫£m v·ªõi li·ªÅu/fx cao
- Hypofractionation c√≥ th·ªÉ c√≥ l·ª£i
- V√≠ d·ª•: U prostate (Œ±/Œ≤=1.5) vs U ƒë·∫ßu c·ªï (Œ±/Œ≤=10)

### 3. Khi n√†o d√πng gi√° tr·ªã n√†o?

**D√πng gi√° tr·ªã th·∫•p (b·∫£o th·ªß)** khi:
- ‚úÖ C∆° quan quan tr·ªçng (t·ªßy s·ªëng, n√£o)
- ‚úÖ Kh√¥ng ch·∫Øc ch·∫Øn v·ªÅ Œ±/Œ≤
- ‚úÖ Mu·ªën an to√†n h∆°n

**D√πng gi√° tr·ªã cao** khi:
- ‚úÖ C√≥ d·ªØ li·ªáu c·ª• th·ªÉ
- ‚úÖ T√≠nh to√°n cho u
- ‚úÖ Hypofractionation

---

## üìä V√≠ d·ª• ·ª©ng d·ª•ng

### V√≠ d·ª• 1: U tuy·∫øn ti·ªÅn li·ªát (Œ±/Œ≤ = 1.5)

**Ph√°c ƒë·ªì chu·∫©n**: 78 Gy / 39 fx (2 Gy/fx)
```
BED = 78 √ó (1 + 2/1.5) = 78 √ó 2.33 = 182 Gy
```

**Hypofractionation**: 60 Gy / 20 fx (3 Gy/fx)
```
BED = 60 √ó (1 + 3/1.5) = 60 √ó 3 = 180 Gy
```

**K·∫øt lu·∫≠n**: BED t∆∞∆°ng ƒë∆∞∆°ng! Hypofractionation c√≥ l·ª£i cho u prostate.

### V√≠ d·ª• 2: U ƒë·∫ßu c·ªï (Œ±/Œ≤ = 10)

**Ph√°c ƒë·ªì chu·∫©n**: 70 Gy / 35 fx (2 Gy/fx)
```
BED = 70 √ó (1 + 2/10) = 70 √ó 1.2 = 84 Gy
```

**Hypofractionation**: 60 Gy / 20 fx (3 Gy/fx)
```
BED = 60 √ó (1 + 3/10) = 60 √ó 1.3 = 78 Gy
```

**K·∫øt lu·∫≠n**: BED gi·∫£m! C·∫ßn c√¢n nh·∫Øc k·ªπ khi hypofractionation.

### V√≠ d·ª• 3: T·ªßy s·ªëng (Œ±/Œ≤ = 2)

**Gi·ªõi h·∫°n chu·∫©n**: 45 Gy / 23 fx (2 Gy/fx)
```
BED = 45 √ó (1 + 2/2) = 45 √ó 2 = 90 Gy
```

**V·ªõi 3 Gy/fx**: Li·ªÅu t·ªëi ƒëa?
```
D_max = 90 / (1 + 3/2) = 90 / 2.5 = 36 Gy
```

**K·∫øt lu·∫≠n**: Gi·∫£m ƒë√°ng k·ªÉ! T·ªßy s·ªëng r·∫•t nh·∫°y c·∫£m v·ªõi li·ªÅu/fx cao.

---

## ‚ö†Ô∏è L∆∞u √Ω quan tr·ªçng

### 1. Gi√° tr·ªã Œ±/Œ≤ l√† ∆∞·ªõc l∆∞·ª£ng

- ‚ùå Kh√¥ng ph·∫£i gi√° tr·ªã tuy·ªát ƒë·ªëi
- ‚ùå C√≥ bi·∫øn ƒë·ªông gi·ªØa c√°c nghi√™n c·ª©u
- ‚úÖ D√πng l√†m tham kh·∫£o
- ‚úÖ C√¢n nh·∫Øc ph·∫°m vi gi√° tr·ªã

### 2. Ph·ª• thu·ªôc endpoint

C√πng m·ªôt c∆° quan c√≥ th·ªÉ c√≥ Œ±/Œ≤ kh√°c nhau cho c√°c endpoint kh√°c nhau:
- Da: Acute erythema (Œ±/Œ≤=10) vs Late fibrosis (Œ±/Œ≤=3)
- Tim: Pericarditis vs Coronary disease
- Ph·ªïi: Pneumonitis vs Fibrosis

### 3. Y·∫øu t·ªë ·∫£nh h∆∞·ªüng

Œ±/Œ≤ c√≥ th·ªÉ thay ƒë·ªïi do:
- Tu·ªïi b·ªánh nh√¢n
- B·ªánh l√Ω n·ªÅn
- H√≥a tr·ªã k·∫øt h·ª£p
- K·ªπ thu·∫≠t x·∫° tr·ªã
- Th·ªùi gian theo d√µi

### 4. Tr·∫ª em (Pediatric)

**KH√îNG d√πng gi√° tr·ªã ng∆∞·ªùi l·ªõn!**
- Tr·∫ª em nh·∫°y c·∫£m h∆°n
- Tham kh·∫£o PENTEC
- C·∫ßn t∆∞ v·∫•n chuy√™n gia

---

## üìö T√†i li·ªáu tham kh·∫£o

### QUANTEC Papers
1. Marks LB et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010.
2. Various organ-specific QUANTEC papers (2010)

### PENTEC Papers
3. Constine LS et al. Pediatric normal tissue effects in the clinic (PENTEC). Int J Radiat Oncol Biol Phys. 2019.

### Specific Studies
4. Prostate Œ±/Œ≤: Miralbell R et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients. Int J Radiat Oncol Biol Phys. 2012.

5. Breast Œ±/Œ≤: Haviland JS et al. The UK Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2013.

6. Spinal Cord: Kirkpatrick JP et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008.

7. Lens: Merriam GR, Worgul BV. Experimental radiation cataract. Bull N Y Acad Med. 1983.

---

## üéØ Khuy·∫øn ngh·ªã

### Cho b√°c sƒ© x·∫° tr·ªã

1. **Ch·ªçn Œ±/Œ≤ ph√π h·ª£p** v·ªõi endpoint quan t√¢m
2. **D√πng gi√° tr·ªã b·∫£o th·ªß** cho c∆° quan quan tr·ªçng
3. **C√¢n nh·∫Øc ph·∫°m vi** kh√¥ng ch·ªâ gi√° tr·ªã trung b√¨nh
4. **Tham kh·∫£o y vƒÉn** m·ªõi nh·∫•t

### Cho v·∫≠t l√Ω x·∫° tr·ªã

1. **Ki·ªÉm tra Œ±/Œ≤** trong NTCP models
2. **Validate** v·ªõi d·ªØ li·ªáu l√¢m s√†ng
3. **Document r√µ r√†ng** gi√° tr·ªã ƒë√£ d√πng
4. **Sensitivity analysis** v·ªõi c√°c gi√° tr·ªã kh√°c nhau

### Cho sinh vi√™n

1. **Hi·ªÉu √Ω nghƒ©a** c·ªßa Œ±/Œ≤
2. **Ph√¢n bi·ªát** early vs late effects
3. **Bi·∫øt ·ª©ng d·ª•ng** trong l√¢m s√†ng
4. **ƒê·ªçc** c√°c paper QUANTEC/PENTEC

---

## ‚úÖ Checklist s·ª≠ d·ª•ng

Khi ch·ªçn Œ±/Œ≤, h√£y t·ª± h·ªèi:

- [ ] ƒê√¢y l√† u hay m√¥ l√†nh?
- [ ] Early hay late effect?
- [ ] Endpoint c·ª• th·ªÉ l√† g√¨?
- [ ] C√≥ d·ªØ li·ªáu c·ª• th·ªÉ cho tr∆∞·ªùng h·ª£p n√†y kh√¥ng?
- [ ] Gi√° tr·ªã n√†y c√≥ b·∫£o th·ªß ƒë·ªß kh√¥ng?
- [ ] C√≥ c·∫ßn tham kh·∫£o chuy√™n gia kh√¥ng?

---

## üéì K·∫øt lu·∫≠n

**B·∫£ng Œ±/Œ≤ l√† c√¥ng c·ª• quan tr·ªçng** trong:
- ‚úÖ T√≠nh to√°n BED/EQD2
- ‚úÖ So s√°nh ph√°c ƒë·ªì
- ‚úÖ L·∫≠p k·∫ø ho·∫°ch x·∫° tr·ªã
- ‚úÖ ƒê√°nh gi√° ƒë·ªôc t√≠nh

**Nh∆∞ng nh·ªõ r·∫±ng**:
- ‚ö†Ô∏è ƒê√¢y l√† ∆∞·ªõc l∆∞·ª£ng, kh√¥ng ph·∫£i gi√° tr·ªã tuy·ªát ƒë·ªëi
- ‚ö†Ô∏è C·∫ßn c√¢n nh·∫Øc nhi·ªÅu y·∫øu t·ªë l√¢m s√†ng
- ‚ö†Ô∏è Quy·∫øt ƒë·ªãnh cu·ªëi c√πng d·ª±a tr√™n kinh nghi·ªám v√† ƒë√°nh gi√° t·ªïng th·ªÉ

**Ph·∫ßn m·ªÅm n√†y** cung c·∫•p c√°c gi√° tr·ªã tham kh·∫£o d·ª±a tr√™n y vƒÉn uy t√≠n, nh∆∞ng **b√°c sƒ© ƒëi·ªÅu tr·ªã** v·∫´n l√† ng∆∞·ªùi ra quy·∫øt ƒë·ªãnh cu·ªëi c√πng!
